• SELECT SITE CURRENCY
Select a currency for use throughout the site
IMS Country Review: Egypt
IMS Health, July 2007, Pages: 50
IMS Health’s Country Profiles provide a comprehensive insight into the national sales of the pharmaceutical market in selected countries over 5 years. Each individual IMS Company Profile analyzes the critical components that make up a pharmaceutical company, providing you with a clear assessment of the relative strengths and weaknesses of a company’s business strategy. Sales performance is analysed in terms of geographic region, major corporations, therapeutic classes, major products and new product activity.
All data is available over a 5 year period for easy trend analysis and is based on Quarter 4 sales figures.
Country Profiles are available for:
Argentina, Australia, Austria, Belgium, Brazil, Canada, China, Czech Republic, Egypt, Finland, France, Germany, India, Indonesia, Italy, Mexico, Netherlands, Poland, Portugal, Russian Federation, South Africa, South Korea, Spain, Switzerland, Taiwan, Turkey, United Kingdom and United States.
Data Values and Definitions
Channels of Distribution
Audited Market Trend
Leading Companies – Top 35
Leading Corporations – Top 35
Fastest Growing Companies
Market Share By Corporate Nationality
15 Largest Therapeutic Classes
15 Fastest-Growing 3rd And 4th Level Therapeutic Classes
Therapeutic Class Profile
Leading Products – Top 40
Leading New Products – Top 40
Forms Most Commonly Used – Top 15
NOVARTIS PH. EGYPT
MEDICAL UNION PHAR
NPE NOVARTIS C.H.
GLOBAL NAPI MSD
AMOUN MERCK AG
A sample for this product is available. Please Login/Register to download this sample.